Other OTC - Delayed Quote USD

MariMed Inc. (MRMD)

0.2666 -0.0006 (-0.22%)
At close: April 26 at 3:56 PM EDT
Key Events
Loading Chart for MRMD
DELL
  • Previous Close 0.2672
  • Open 0.2700
  • Bid --
  • Ask --
  • Day's Range 0.2550 - 0.2890
  • 52 Week Range 0.2030 - 0.5450
  • Volume 172,878
  • Avg. Volume 459,603
  • Market Cap (intraday) 100.01M
  • Beta (5Y Monthly) 2.87
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date May 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.50

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

www.marimedinc.com

643

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MRMD

Performance Overview: MRMD

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MRMD
3.05%
S&P 500
6.92%

1-Year Return

MRMD
28.91%
S&P 500
25.26%

3-Year Return

MRMD
60.33%
S&P 500
22.00%

5-Year Return

MRMD
91.90%
S&P 500
74.29%

Compare To: MRMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MRMD

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    100.01M

  • Enterprise Value

    165.40M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.65

  • Price/Book (mrq)

    1.40

  • Enterprise Value/Revenue

    1.11

  • Enterprise Value/EBITDA

    14.82

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.79%

  • Return on Assets (ttm)

    5.41%

  • Return on Equity (ttm)

    -17.40%

  • Revenue (ttm)

    148.6M

  • Net Income Avi to Common (ttm)

    -16.03M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.73M

  • Total Debt/Equity (mrq)

    90.11%

  • Levered Free Cash Flow (ttm)

    -403.62k

Research Analysis: MRMD

Analyst Price Targets

0.50
0.50 Average
0.2666 Current
0.50 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: MRMD

People Also Watch